Similarly, mice pre-treated with AAV9-Tert did not show any significant differences in the incidence of adenomas and carcinomas compared to mice treated with the AAV9-Null or to mice not treated with viruses (mock) (Fig 2B–2C). This evidence concerns the gene TERT and adenoma.